BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27906778)

  • 1. The role of prostatic inflammation in the development and progression of benign and malignant diseases.
    Gandaglia G; Zaffuto E; Fossati N; Cucchiara V; Mirone V; Montorsi F; Briganti A
    Curr Opin Urol; 2017 Mar; 27(2):99-106. PubMed ID: 27906778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
    Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
    BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between benign prostatic hyperplasia and inflammation.
    Bostanci Y; Kazzazi A; Momtahen S; Laze J; Djavan B
    Curr Opin Urol; 2013 Jan; 23(1):5-10. PubMed ID: 23159991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
    Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
    Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
    Lloyd GL; Marks JM; Ricke WA
    Curr Urol Rep; 2019 Aug; 20(9):54. PubMed ID: 31377881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
    Chiang BJ; Kuo HC; Liao CH
    Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
    Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer].
    Zhang F; Si-Mu-Jiang-Abula A; Zhang LD
    Zhonghua Nan Ke Xue; 2014 Apr; 20(4):354-8. PubMed ID: 24873164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
    Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
    Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?
    Kim SH; Jung KI; Koh JS; Min KO; Cho SY; Kim HW
    Urol Int; 2013; 90(2):144-9. PubMed ID: 23295780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Knowledge of the Potential Links between Inflammation and Prostate Cancer.
    Cai T; Santi R; Tamanini I; Galli IC; Perletti G; Bjerklund Johansen TE; Nesi G
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammation and benign prostatic hyperplasia: cause or consequence?].
    Robert G; Salagierski M; Schalken JA; de La Taille A
    Prog Urol; 2010 Jun; 20(6):402-7. PubMed ID: 20538203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review.
    Tsunemori H; Sugimoto M
    Int J Urol; 2021 Nov; 28(11):1086-1092. PubMed ID: 34342061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)?
    Ficarra V
    BJU Int; 2013 Aug; 112(4):421-2. PubMed ID: 23879899
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and its Potential Impact on Medical Therapy.
    Kaplan SA
    J Urol; 2016 Mar; 195(3):689-90. PubMed ID: 26887734
    [No Abstract]   [Full Text] [Related]  

  • 20. Testosterone and Benign Prostatic Hyperplasia.
    Rastrelli G; Vignozzi L; Corona G; Maggi M
    Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.